T6712 |
Tyrphostin AG 879
|
148741-30-4
|
98%
|
|
Tyrphostin AG 879 effectively inhibits HER2/ErbB2 (IC50: 1 μM), 100- and 500-fold higher selective to ErbB2 than EGFR and PDGFR.
|
T13178 |
Toceranib
|
356068-94-5
|
98%
|
|
Toceranib phosphate is an orally active inhibitor of tyrosine kinase (RTK) receptor, and it potently inhibits PDGFR, VEGFR, and Kit(with Kis of 5 and 6 nM for PD...
|
T2456 |
Tivozanib
|
475108-18-0
|
98%
|
|
Tivozanib is an orally bioavailable inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1, 2 and 3 with potential antiangiogenic and antineoplasti...
|
T8541 |
Lenvatinib mesylate
|
857890-39-2
|
98%
|
|
Lenvatinib mesylate is an oral and multi-targeted inhibitor of VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, with potent antitumor activities.
|
T1895 |
SKLB 610
|
1125780-41-7
|
98%
|
|
SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2, and PDGFR at a rate of 97%, 65%, and 55%, respectively, a...
|
T16947 |
SU16f
|
251356-45-3
|
98%
|
|
SU16f is a potent and selective PDGFRβ inhibitor (IC50s: 10 nM, 140 nM, 2.29 μM for PDGFRβ, PDGFR1, PDGFR2, respectively). Neutralization of PDGFRβ receptor by S...
|
T6230 |
Imatinib
|
152459-95-5
|
98%
|
|
matinib is an inhibitor of the receptor tyrosine kinases c-Abl, Bcr-Abl, PDGFR, and c-Kit (IC50: 600/100/100 nM).
|
T1792L |
Regorafenib monohydrate
|
1019206-88-2
|
98%
|
|
Regorafenib Monohydrate is a novel oral multikinase inhibitor with IC50 values of 13, 4.2, 46, 22, 7, 1.5, 2.5, 28, 19 nM for VEGFR1, murine VEGFR2, murine VEGFR...
|
T6930 |
Pazopanib Hydrochloride
|
635702-64-6
|
98%
|
|
Pazopanib HCl (GW786034 HCl) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, 30 nM, 47 nM, 84 nM, 7...
|
TN1969 |
N-(p-Coumaroyl) serotonin
|
68573-24-0
|
98%
|
|
N-(p-Coumaroyl) Serotonin is a polyphenol isolated from the seeds of safflower. N-(p-Coumaroyl) serotonin has antioxidant, cardioprotective effects after ischemi...
|
T1621 |
Imatinib Mesylate
|
220127-57-1
|
98%
|
|
Imatinib mesylate is a tyrosine kinase receptor inhibitor with antineoplastic activity (IC50s: 0.6 μM, 0.1 μM and 0.1 μM for v-Abl, c-Kit and PDGFR, respectively...
|
T5001 |
Nintedanib esylate
|
656247-18-6
|
98%
|
|
BIBF 1120 esylate is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β
|
TQ0235 |
AC710
|
1351522-04-7
|
98%
|
|
AC710 is a potent PDGFR inhibitor (Kds: 0.6, 1, 1.57, 1.3, 1 nM for FLT3, KIT, CSF1R, PDGFRα and PDGFRβ).
|
T4320 |
Flumatinib
|
895519-90-1
|
98%
|
|
Flumatinib is an orally bioavailable tyrosine kinase inhibitor flumatinib, with potential antineoplastic activity.
|
T3570 |
SU4312
|
5812-07-7
|
98%
|
|
SU-4312, also known as DMBI, is a potent and selective inhibitor of VEGFR and PDGFR tyrosine kinases (IC50 values are 0.8 and 19.4 μM respectively). SU4312 unexp...
|
T13156L |
TG 100572 Hydrochloride
|
867331-64-4
|
98%
|
|
TG 100572 Hydrochloride is a inhibitor of multi-targeted kinase which inhibits receptor tyrosine kinases and Src kinases(IC50s of 2, 7, 2, 16, 13, 5, 0.5, 6, 0.1...
|
T14137 |
AG 1295
|
71897-07-9
|
98%
|
|
AG 1295 is a selective platelet-derived growth factor receptor (PDGFR) tyrosine-kinase inhibitor. AG1295 abolishes autophosphorylation of the PDGFR. But it can n...
|
T9030 |
SU4984
|
186610-89-9
|
98%
|
|
SU4984 is a cell-permeable, ATP-competitive and reversible inhibitor of the fibroblast growth factor receptor 1 (FGFR1).
|
T1991 |
ZM323881 hydrochloride
|
193000-39-4
|
98%
|
|
ZZZM 323881 hydrochloride is a potent and selective VEGFR2 inhibitor.
|
T7104 |
Dovitinib lactate
|
692737-80-7
|
98%
|
|
Dovitinib lactate(TKI258) lactate is a potent inhibitor of fibroblast growth factor receptor 3 (FGFR3) (IC50 :5 nM).
|